Ebola (rVSV-ZEBOV)
Ebola Vaccine rVSV-ZEBOV (Ervebo)
Platform: Recombinant vesicular stomatitis virus
Licensed vaccine that protects against Ebola virus disease, used in outbreak response through ring vaccination strategy.
PubMed References
Immunology Sections
Curated section analysis in progress
Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.
Verified References
Wikipedia Overview
Full article ↗
An Ebola vaccine is a vaccine used to prevent Ebola virus disease (Ebola). As of 2022, there are only two vaccines against the Zaire ebolavirus. The first vaccine to be approved in the United States is rVSV-ZEBOV in December 2019. It had been used extensively in the Kivu Ebola epidemic under a compassionate use protocol. During the early 21st century, several vaccine candidates displayed efficacy to protect nonhuman primates against lethal infection.
PubMed Literature
Search PubMed ↗No PubMed results retrieved.
Semantic Scholar
Search S2 ↗No Semantic Scholar results retrieved.